Clinical Trial Update: Evaluation of Efficacy of Zoledronic Acid in Patients With Haemoglobin Syndromes (Thalassemia and Sicle Cell Anaemia) and Risk of Skeletal Events [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating the efficacy of zoledronic acid in patients with hemoglobin disorders (thalassemia and sickle cell disease) at risk for skel…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sickle Cell Disease
• Thalassemia

Drugs mentioned

• Zoledronic acid (Zoledronic acid)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Thalassemia | Phase 4 | Status: COMPLETED